Plain-English translation of NCT04796350 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether AGN1 LOEP, a local bone-strengthening procedure, can help prevent a second hip fracture in women with osteoporosis. Half of participants will receive standard hip fracture repair surgery plus the AGN1 LOEP treatment on their healthy hip, while the other half will receive standard repair surgery alone. The study will follow participants for at least 5 years to see which group has fewer second hip fractures.
Many women who break one hip go on to break the other hip within a few years, especially if they have weak bones from osteoporosis. This treatment aims to strengthen the healthy hip bone right after the first fracture is repaired, hopefully preventing that second, devastating fracture.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have hip fracture repair surgery as usual. At the same time, you will either receive the AGN1 LOEP procedure on your healthy hip (treatment group) or no additional procedure (control group). You will then return for follow-up visits at 6 weeks, 6 months, and every 6 months after that for at least 5 years. At each visit, your doctors will check on your healing and ask about any falls or new fractures.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Austria
Belgium